Overview
Naoyuki Miyagawa practices in Yokohama, Japan. Miyagawa is rated as an Advanced expert by MediFind in the treatment of Leukemoid Reaction. Their top areas of expertise are Leukemoid Reaction, Acute Myelomonocytic Leukemia, Acute Lymphoblastic Leukemia (ALL), and Leukemia.
Their clinical research consists of co-authoring 21 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Leukemoid Reaction.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Leukemoid ReactionMiyagawa isAdvanced. Learn about Leukemoid Reaction.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Miyagawa isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloid Leukemia (AML)Miyagawa isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaMiyagawa isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Brain Stem CancerMiyagawa isExperienced. Learn about Brain Stem Cancer.
- Childhood Acute Myeloid LeukemiaMiyagawa isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Diffuse Midline Glioma H3 K27M-Mutant